Home›People›Steven Gillis
SG

Steven Gillis

Managing Director at ARCH Venture Partners

Director
Updated Oct 25, 2026·Latest SEC filing Jun 30, 2026·Suggest an edit

About Steven Gillis

Steven Gillis, PhD, is a managing director at ARCH Venture Partners, which led SonoThera's Series A, and he sits on SonoThera's board. He was a founder of Immunex and of Corixa, which GlaxoSmithKline acquired in 2005.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Steven Gillis in the role, so the role may have started earlier or lasted longer.

ARCH Venture Partners Current
Managing Director (2006 – Present)
Venture Partner (2005 – 2006)
2005 – Present
HiberCell Current
Chairman and acting CEO
SonoThera, Inc.
Director
2022 – 2026 · South San Francisco, CA
SonoThera develops nonviral genetic medicines that use ultrasound and imaging microbubbles to deliver DNA and RNA into chosen organs, starting with Duchenne muscular dystrophy.
Corixa Corp.
Founder, Director and CEO (2005)
Chairman (1999 – 2005)
1999 – 2005
Immunex Corp.
Founder and Director (1997)
Director of Research and Development, Chief Scientific Officer (1981 – 1994)
Interim CEO
1981 – 1997
beBio
Board member
Inograft
Board member
Dispatch Bio
Board member
Carrick Therapeutics
Board member
eGenesis (Chairman)
Board member
Skylark Bio (Chairman)
Board member
Walden Biosciences (Chairman)
Board member
OncoResponse (Chairman)
Board member
Mozart Therapeutics (Chairman)
Board member
Bitterroot Bio (Chairman)
Board member
Vilya (Chairman)
Board member
Lifordi Immunotherapeutics (Chairman)
Board member
Basking Bio (Chairman)
Board member
TFC Therapeutics (Chairman)
Board member
Pheast Therapeutics (Chairman)
Board member
Proniras (Chairman)
Board member
Balsam Bio (Chairman)
Board member
Takeda Pharmaceuticals
Board member

Education

  • BA, Williams College
  • PhD, Dartmouth College

Key Colleagues at Startups

The people Steven Gillis works with at each company, as listed on that company's latest Form D.

SonoThera, Inc. · Form D, Jun 30, 2026
SF
Steven Feinstein
Co-founder & Chief Scientific Officer
KG
Kenneth Greenberg
Co-founder, President & CEO, director
MD
Michael Davidson
Co-founder & Executive Chairman
RJ
Rajul Jain
Director
CZ
Carolyne Zimmermann
Chief Business Officer
BH
Brian Halak
Director

Sources

  1. SECSonoThera, Inc. Form D, filed Jun 30, 2026
  2. Officialsonothera.com, board page
  3. Officialsonothera.com, Series B release (Managing Director at ARCH Venture Partners)